Inhibition of angiogenesis mediated by extremely low-frequency magnetic fields (ELF-MFs).
The formation of new blood vessels is an essential therapeutic target in many diseases such as cancer, ischemic diseases, and chronic inflammation. In this regard, extremely low-frequency (ELF) electromagnetic fields (EMFs) seem able to inhibit vessel growth when used in a specific window of amplitude. To investigate the mechanism of anti-angiogenic action of ELF-EMFs we tested the effect of a sinusoidal magnetic field (MF) of 2 mT intensity and frequency of 50 Hz on endothelial cell models HUVEC and MS-1 measuring cell status and proliferation, motility and tubule formation ability. MS-1 cells when injected in mice determined a rapid tumor-like growth that was significantly reduced in mice inoculated with MF-exposed cells. In particular, histological analysis of tumors derived from mice inoculated with MF-exposed MS-1 cells indicated a reduction of hemangioma size, of blood-filled spaces, and in hemorrhage. In parallel, in vitro proliferation of MS-1 treated with MF was significantly inhibited. We also found that the MF-exposure down-regulated the process of proliferation, migration and formation of tubule-like structures in HUVECs. Using western blotting and immunofluorescence analysis, we collected data about the possible influence of MF on the signalling pathway activated by the vascular endothelial growth factor (VEGF). In particular, MF exposure significantly reduced the expression and activation levels of VEGFR2, suggesting a direct or indirect influence of MF on VEGF receptors placed on cellular membrane. In conclusion MF reduced, in vitro and in vivo, the ability of endothelial cells to form new vessels, most probably affecting VEGF signal transduction pathway that was less responsive to activation. These findings could not only explain the mechanism of anti-angiogenic action exerted by MFs, but also promote the possible development of new therapeutic applications for treatment of those diseases where excessive angiogenesis is involved.
Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Simona
S
Delle Monache
Adriano
A
Angelucci
Patrizia
P
Sanità
Roberto
R
Iorio
Francesca
F
Bennato
Fabrizio
F
Mancini
Giancaterino
G
Gualtieri
Rosella Cardigno
RC
Colonna
D000818:Animals; D002453:Cell Cycle / Q000528:radiation effects; D002460:Cell Line; D002465:Cell Movement / Q000528:radiation effects; D049109:Cell Proliferation / Q000528:radiation effects; D004574:Electromagnetic Fields; D042783:Endothelial Cells / Q000528:radiation effects; D061307:Human Umbilical Vein Endothelial Cells / Q000528:radiation effects; D006801:Humans; D060526:Magnetic Fields; D051379:Mice; D009389:Neovascularization, Pathologic / Q000378:metabolism / Q000628:therapy; D018919:Neovascularization, Physiologic / Q000502:physiology / Q000528:radiation effects*; D015398:Signal Transduction / Q000528:radiation effects; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000378:metabolism
D040301:Vascular Endothelial Growth Factor Receptor-2